Potassium in Haemodialysis Fluids and Haemodynamics
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01224314 |
Recruitment Status :
Completed
First Posted : October 20, 2010
Last Update Posted : October 20, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Haemodialysis | Other: Changing potassium concentration in dialysis fluids | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 24 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Haemodynamic Consequences of Changing Potassium Concentrations in Haemodialysis Fluids |
Study Start Date : | September 2007 |
Actual Primary Completion Date : | December 2007 |
Actual Study Completion Date : | December 2007 |

Arm | Intervention/treatment |
---|---|
Active Comparator: dialysis fluid potassium high
potassium concentration in the dialysis fluid 1 mmol/L higher than usual
|
Other: Changing potassium concentration in dialysis fluids
The dialysis sessions was divided into 3 tertiles, casually modulating potassium concentration in the dialysate between the value normally used K and the two cut-off points K+1 and K-1 mmol/l
Other Name: Potassium concentrations in haemodialysis fluids |
Active Comparator: dialysis fluid potassium low
potassium concentration in the dialysis fluid 1 mmol/L lower than usual
|
Other: Changing potassium concentration in dialysis fluids
The dialysis sessions was divided into 3 tertiles, casually modulating potassium concentration in the dialysate between the value normally used K and the two cut-off points K+1 and K-1 mmol/l
Other Name: Potassium concentrations in haemodialysis fluids |
- haemodynamic consequences of dialysate potassium concentration [ Time Frame: 4 weeks ]difference in haemodynamic parameters between the extremes in potassium concentration of the dialysate
- incidence of hypotension [ Time Frame: 4 weeks ]incidence of hypotension during dialysis

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- chronic haemodialysis patients
- dialysed 3 to 4 hours three times a week
- clinically stable and without intercurrent illnesses
Exclusion Criteria:
- intercurrent illnesses

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01224314
Switzerland | |
Ospedale Regionale di Locarno | |
Locarno, Ti, Switzerland, 6600 |
Principal Investigator: | Luca Gabutti, MD | Ospedale Regionale di Locarno |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Luca Gabutti MD, Division of Nephrology, Ospedale la Carità, Via Ospedale, 6600 Locarno,Switzerland |
ClinicalTrials.gov Identifier: | NCT01224314 |
Other Study ID Numbers: |
010010 |
First Posted: | October 20, 2010 Key Record Dates |
Last Update Posted: | October 20, 2010 |
Last Verified: | August 2007 |
Haemodynamics Hypotension Potassium Haemodialysis Dialysis fluids |
Dialysis Solutions Pharmaceutical Solutions |